Dermatologicals in Sweden

 Published On: Oct, 2016 |    No of Pages: 24 |  Published By: Euromonitor | Format: PDF
Current value growth of 2% in 2016 was relatively sluggish if viewed in the context of the 3% gain recorded by consumer health as a whole. Dermatologicals is a very mature category in Sweden, with relatively few growth opportunities. Competition from generics is growing, thus leading to strong price competition.

Dermatologicals in Sweden report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the marketís major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
DERMATOLOGICALS IN SWEDEN

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2011-2016
Table 2 Sales of Dermatologicals by Category: % Value Growth 2011-2016
Table 3 NBO Company Shares of Dermatologicals: % Value 2012-2016
Table 4 LBN Brand Shares of Dermatologicals: % Value 2013-2016
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2013-2016
Table 6 Forecast Sales of Dermatologicals by Category: Value 2016-2021
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2016-2021
Meda Ab in Consumer Health (sweden)
Strategic Direction
Key Facts
Summary 1 Meda AB: Key Facts
Summary 2 Meda AB: Operational Indicators
Competitive Positioning
Summary 3 Meda AB: Competitive Position 2016
Executive Summary
Further Positive Value Growth Registered in 2016
Rising Health Awareness Supports Growth
Fragmented Competitive Environment
Distribution Split Between A Number of Channels
Onwards and Upwards
Key Trends and Developments
Lifestyle Habits Give Rise To Obesity Concerns
Growing Demand for Snus
New Consumers Demanding More Sophisticated Products
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 4 OTC: Switches 2014-2016
Sources
Summary 5 Research Sources

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.